Everfront Biotech Holding Company Limited (EFB)
Everfront Biotech Holding Company will go public soon, but the exact IPO date is still unknown.
Stock Price: Pending
IPO price not available yet
Company Description
Everfront Biotech IS a clinical stage biopharmaceutical company dedicated to the discovery, development and commercialization of new drugs that have potential as treatments for patients with cancers, neurodegenerative diseases and rare diseases.
We are conducting three clinical trials in Taiwan under the approval of the United States Food and Drug Administration and the Taiwan Food and Drug Administration.
As of the date of this prospectus, we have no products approved for commercial sale and have never generated any revenue from product sales.
Everfront Biotech Holding Company Limited
| Country | Taiwan |
| Founded | 2010 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 14 |
| CEO | Dr. TZA-ZEN CHAUNG |
Contact Details
Address: 10F-1, No.130, Songshan Rd., Xinyi Dist. Taipei, 110 Taiwan | |
| Phone | +886-2-2756-3796 |
| Website | efbiotech.com |
Stock Details
| Ticker Symbol | EFB |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0002001611 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Dr. TZA-ZEN CHAUNG | Chief Executive Officer |
| PI-CHUAN CHIEN | Chief Financial Officer |
| Dr. YU-FANG HU | Chief Operating Officer |
| Dr. JEN-WEI LIU | Chief Scientific Officer |
| Dr. YUAN-SHENG LI | Chief Technology Officer |
| HO-CHING CHEN | Director |
| Dr. PEI-WEN CHOU | Director |
| HANN-CHYI LIN | Independent Director |
| Dr. TAI-NANG HUANG | Independent Director |
| YIN-HO HUANG | Independent Director |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jun 23, 2025 | F-1/A | [Amend] Registration statement for certain foreign private issuers |
| Jan 3, 2025 | F-1 | Registration statement for certain foreign private issuers |
| Dec 6, 2024 | DRS/A | [Amend] [Cover] Draft Registration Statement |
| Sep 27, 2024 | DRS/A | [Amend] [Cover] Draft Registration Statement |
| Aug 22, 2024 | DRS/A | [Amend] [Cover] Draft Registration Statement |
| Jun 14, 2024 | DRS | [Cover] Draft Registration Statement |